• Berberrubine and the Gut–Liver Axis in NAFLD

  2026-08-23

  A 2022 Frontiers in Pharmacology study examined berberrubine, a major berberine metabolite, as an active mediator of protection against diet- and fatty-acid-associated metabolic liver injury. Its comparative mouse, HepG2-cell, protein-expression, and 16S rRNA sequencing data connect improved steatosis and insulin resistance with altered glucose and lipid metabolism and remodeling of gut microbial communities.

• HyperScript First-Strand cDNA Synthesis Kit Guide

  2026-08-22

  The HyperScript First-Strand cDNA Synthesis Kit uses HyperScript Reverse Transcriptase to generate first-strand cDNA from purified total RNA or poly(A)+ RNA. Its reported thermal stability, reduced RNase H activity, primer options, and cDNA length capability support RNA template reverse transcription for PCR amplification and qPCR reaction workflows.

• HyperFluor 488 for SCI Inflammation Imaging

  2026-08-21

  Discover how HyperFluor 488 Goat Anti-Rabbit IgG converts pathway-focused spinal cord injury research into spatially resolved fluorescence measurements. This article connects antibody architecture, microglia–neuron models, controls, and interpretation beyond routine immunofluorescence workflows.

• Canagliflozin and mTOR: A Translational Boundary

  2026-08-20

  Canagliflozin is best understood as a pathway-selective SGLT2 inhibitor, not a direct mTOR inhibitor. New yeast drug-sensitization data provide a valuable boundary condition: canagliflozin showed no evidence of TOR inhibition in that model, while multiple established TOR inhibitors produced selective growth phenotypes. This distinction helps translational researchers design cleaner glucose metabolism studies, choose appropriate controls, and avoid overstating cross-pathway conclusions.

• Hyperforin Targets Dlat–Trpv3 Thermogenesis

  2026-08-20

  The reference study identifies a non-canonical Dlat–Trpv3–Ca2+–Camkkb–AMPK pathway through which hyperforin promotes adipose thermogenesis without relying on β3-adrenergic stimulation. Its combination of Dlat heterozygous mice, pharmacokinetic analysis, metabolic phenotyping, and cellular assays provides a mechanistic framework for evaluating thermogenic anti-obesity strategies while highlighting important translational limitations.

• StrR-Like Regulators and A40926 Production

  2026-08-19

  The reference study shows that StrR-like transcriptional regulators from distant lipodepsipeptide pathways can activate glycopeptide antibiotic production in heterologous actinobacterial hosts. Its strongest practical implication is that regulator selection should be based on functional compatibility, not phylogenetic proximity alone, when improving teicoplanin or A40926 biosynthesis.

• HotStart 2X Green qPCR Master Mix for RCC

  2026-08-19

  Build a reproducible SYBR Green workflow for tracking LDHA-driven metabolism and sunitinib response in renal cell carcinoma models. This practical guide combines hot-start specificity, melt-curve quality control, and assay design for gene expression analysis and RNA-seq validation.

• Ivermectin: From Parasite Target to Assay Insight

  2026-08-18

  Ivermectin is a broad-spectrum anti-parasitic whose value in research depends on mechanism-aligned assay design. This article connects parasite neuromuscular pharmacology with the assay logic of a pivotal Gasdermin C pancreatic cancer study while clearly separating established evidence from exploratory interpretation.

• Clathrin-Mediated Entry of Type III GCRV

  2026-08-18

  Wang et al. used pharmacological inhibitors, transmission electron microscopy, and quantitative PCR to define how genotype III grass carp reovirus enters CIK cells. Their results implicate a dynamin-dependent, clathrin-mediated, pH-sensitive endocytic route and distinguish this pathway from nystatin-sensitive membrane entry mechanisms.

• Firefly Luciferase mRNA as a Delivery Probe

  2026-08-17

  Firefly Luciferase mRNA can do more than report gene expression: it can help dissect how mRNA chemistry, carrier design, and intracellular translation interact. This article connects 5-moUTP modified mRNA with targeted LNP evaluation and practical assay architecture.

• Cy3 Goat Anti-Mouse IgG (H+L) Antibody

  2026-08-17

  Cy3 Goat Anti-Mouse IgG (H+L) Antibody provides fluorescent detection of mouse primary antibodies in immunofluorescence, flow cytometry, and western blot workflows. It is intended for research use only; working dilutions, assay-specific performance, and diagnostic suitability must be established by the laboratory.

• CTOP and the Circuit Logic of Opioid Pain

  2026-08-16

  CTOP provides a selective pharmacological lens for testing how μ-opioid receptor activity contributes to brain-to-spinal control of mechanical hypersensitivity and analgesic tolerance. This thought-leadership guide connects recent circuit findings with practical validation strategies for translational neuropharmacology and pain mechanism research.

• MLN4924 HCl salt: Reliable Assay Design

  2026-08-15

  Learn how MLN4924 HCl salt, SKU A3629, can improve interpretation of viability, proliferation, cell-cycle, and protein-degradation experiments through controlled NAE inhibition. This scenario-based guide covers formulation, experimental controls, cross-domain applications, and practical vendor-selection criteria.

• Prostaglandin E2 Workflows for Immune Research

  2026-08-14

  Build receptor-aware Prostaglandin E2 assays for inflammation research, immune regulation, and translational model development. This guide connects practical PGE2 handling with new evidence that arachidonic acid can accelerate vaccine-induced humoral immunity, while keeping PGE2-specific conclusions experimentally distinct.

• Thiamet G and O-GlcNAc Control of Trophoblast Stress

  2026-08-14

  Thiamet G is a selective O-GlcNAcase inhibitor for experimentally increasing protein O-GlcNAcylation. This article connects its pharmacology to a new ferroptosis–HUWE1–TfR1 framework in trophoblast stress and explains how to design more informative mechanistic assays.

451 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page